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ABSTRACT 
Galactose is a simple sugar that at supraphysiological concentrations accelerates 
aging and age-related complications, which lead to impaired mitochondrial functions. 
MitoNEET is a small mitochondrial membrane protein with a molecular mass of 12.2 
kDa that functions in diabetes, iron metabolism, regulation of oxidative phosphorylation 
(OXPHOS) and reactive oxygen species (ROS) homeostasis. MitoNEET knockdown 
increases cellular respiration rates and ROS levels similar to galactose treatment. 
Pioglitazone, an antidiabetic drug, binds to mitoNEET and ameliorates galactose toxicity. 
Cellular mitoNEET levels, exposure of cells to galactose medium, and pioglitazone 
treatment directly influence cellular respiration. To elucidate the role of mitoNEET in 
galactose induced toxicity (aging), we measured cellular mitoNEET levels using 
immunoblotting technique in galactose and pioglitazone treated human liver cancer cells 
(HepG2), as well as isolated synaptosomes from old and young mice. We also monitored 
liver cancer cell bioenergetics, using respirometry and calorimetry, of galactose and 
pioglitazone treated cells. Immunoblotting revealed treatment with galactose reduced 
endogenous mitoNEET levels and those of a chimeric mitoNEET protein fused to a green 
fluorescent protein (mNT-GFP), under control of the human cytomegalovirus (CMV) 
promotor. Furthermore, to determine whether mitoNEET mediates pioglitazone 
ameliorated galactose toxicity, cells were treated with pioglitazone. Pioglitazone rescued 
galactose reduced mitoNEET levels in a dose dependent manner. A concentration of 60 
µM pioglitazone reduced cellular mitoNEET levels compared to controls but not mNT­
GFP levels. However, pioglitazone at lower concentrations partially restored mitoNEET 
levels observed with galactose treatment. Since the synthesis of endogenous mitoNEET 
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and m.NT-GFP are regulated by different promoters, D-galactose treatment likely 
increased degradation rates of mitoNEET. Moreover, unlike galactose treatment in 
HepG2 cells, immunoblotting revealed higher mitoNEET levels in synaptosomes isolated 
from aged mice compared to their younger counterparts. We hypothesized that galactose 
and pioglitazone interact with mitoNEET and alter cellular bioenergetics. Acute 
treatment with pioglitazone significantly reduced complex I respiration in HepG2 and 
HepG2-mNT-GFP cells independent of treatment with galactose. Surprisingly, galactose 
treated HepG2-mNT-GFP cells were less sensitive to pioglitazone treatment. HepG2 cells 
treated with galactose and HepG2-mNT-GFP cells independent of treatment showed 
higher OXPHOS activity compared to controls in absence of galactose, but HepG2-mNT­
GFP cells did not respond to galactose treatment. Unlike respiration, galactose treatment 
significantly reduced cellular heat flow in HepG2 and HepG2-mNT-GFP cells measured 
via calorimetry. However, HepG2-mNT-GFP and pioglitazone treated cells showed 
higher heat dissipation compared to control HepG2 cells without galactose. Our results 
show that mitoNEET overexpression increases respiration rates and overall energy 
transduction in HepG2 cells but does not impact the response to pioglitazone treatment. 
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INTRODUCTION 
Mitochondria 
Aerobic mitochondria in mammalian cells are double membrane bounded 
organelles. The outer membrane is made up of a phospholipid bilayer which is permeable 
to molecules less than 5000 Da due to the presence of Voltage-dependent Anion Channel 
(VDAC) proteins (Lemasters et al., 2006). The nearly impermeable inner membrane is 
significantly different from the outer membrane in composition because of the presence 
of cardiolipin, respiratory complexes, and remnants of ancestral bacteria (McBride et al., 
2006). The inner membrane is folded into compartmentalized structures called cristae. 
Five different enzymatic complexes, which take part in the terminal breakdown of food in 
the presence of oxygen termed electron transport chain (ETC), are embedded in the 
cristae (Koopman et al., 2013). Three complexes out of five (complex I, complex III and 
complex IV) of the ETC pump protons into the intermembrane space establishing proton 
motive force (PMF) across the membrane during the reduction of oxygen to water, and 
the fifth complex generates ATP (Fig. 1) by using the established PMF (Brown 1992). 
In terms of energy requirement, every eukaryotic organism depends on organelles 
of mitochondrial origin (mitosomes) which may or may not generate ATP (Miiller et al., 
2012). Most eukaryotic organisms contain mitochondria that produce ATP. Aerobic 
mitochondria exclusively use oxygen as the terminal electron acceptor in the ETC, but 
other types of mitochondria, such as anaerobic mitochondria (H2-producing mitochondria 
and hydrogenosomes), use chemical compounds other than oxygen for this purpose 
(Miiller et al., 2012). The energy required to fuel mitochondrial activity is derived from 
organic biomolecules (food materials) which are broken down into simpler units through 
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a series of stepwise enzymatic reactions. Glucose (6 carbon sugar) for example is being 
broken down into pyruvate (3 carbon alpha-keto acid) in the cell cytoplasm (anaerobic 
glycolysis) (Scrutton and Utter 1 968) .  During this process a part of the chemical energy 
' 
' 
B 
��r-------- Outer membrane 
--=�--- Inter membrane space 
Inner membrane 
----�- Mitochondrial matrix 
} Outer membrane 
} Inter membrane space 
} Inner membrane 
} Mitochondrial matri> 
Figure 1 .  Structure of mitochondrion (A) general outline and (B) in details showing 
porous outer mitochondrial membrane due to presence of VDAC protein, respiratory 
complexes (I through V) , ubiquinone embedded in inner membrane (Q), cytochrome 
c in inter membrane space attached to inner membrane (Cyt-c) and flow of proton 
across the inner membrane (dark arrows), (Eng et al. ,  2003) 
is transferred to the oxidized nicotinamide adenine dinucleotide (NAD+) in the form of 
electrons generating the reduced form of NADH. In canonical oxygen-respiring 
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mitochondria (rat-liver type mitochondria), pyruvate generated in the cytoplasm is 
transported to the mitochondria via the mitochondrial pyruvate carrier (Halestrap 1975) 
Furthermore, pyruvate is broken down into carbon dioxide (C02) and acetyl­
Coenzyme A (acetyl-CoA) via pyruvate dehydrogenase complex (Patel and Korotchkina 
2006), and acetyl-CoA enters into the tricarboxylic (TCA) acid cycle (also called the 
Krebs cycle) located within the mitochondrial matrix to generate intra-mitochondrial 
NADH, FADH2 (reduced flavin adenine dinucleotide) and C02 (Femie and Carrari 2004) 
. In addition, breakdown of fat takes place in the mitochondrial matrix and peroxisome 
and both organelles can generate acetyl-CoA (Lazarow 1978, Wallace et al., 2010). 
Similarly, amino acids are first deaminated and decarboxylated and processed to 
pyruvate, succinyl-CoA, acetyl-CoA, fumarate, a-keto-glutarate and oxaloacetate, which 
are intermediate products of the TCA cycle. The intermediates of the TCA cycle are also 
used for the synthesis of other metabolites and precursors of macromolecules including 
amino acids, nucleotides etc. (Wallace et al., 2010, Reddy and Reddy 2011). Unlike 
pyruvate, the cytosolic proton carrier NADH is not transported into the mitochondrial 
matrix but their oxidation supports the malate-aspartate shuttle system through the 
cytosolic NADH/cytochrome c electron transport pathway. Two different pathways, the 
glutamate dehydrogenase pathway and the aspartate aminotransferase pathway, generate 
a-ketoglutarate inside the mitochondria. The malate-aspartate shuttle system is linked to 
the a-ketoglutarate generated by glutamate dehydrogenase (Abbrescia et al., 2012). 
The mitochondrial matrix is densely packed with enzymes for the Krebs cycle, 
except succinate dehydrogenase (complex II) which is associated with the inner 
mitochondrial membrane. Three molecules of reduced NADH, and one molecule of ATP 
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and FADH2 are produced from the oxidation of acetyl-CoA and two molecules of C02 
are released. The electrons from these energy rich molecules are transferred to oxygen 
through the ETC, which releases energy. During the transfer of electrons from higher 
energy compounds to lower energy centers, complex I, complex III and complex IV 
pump protons from the matrix to the intermembrane space generating an electrochemical 
gradient across the inner membrane (Mitchell 196 1). 
Mitochondria are semiautonomous cell organelles that contain their own DNA 
(mtDNA). There are 92 different genes encoding various subunits of the respiratory 
complexes and ATP synthase proteins in the nuclear DNA and mtDNA. In total, 13 
respiratory complexes and ATP synthase proteins subunits, two genes for mitochondrial 
ribosomal RNAs (mt-rRNA) and 22 mitochondrial transfer RNAs (tRNA) are coded in 
mtDNA. The remaining proteins that are essential for proper mitochondrial function are 
encoded by nuclear DNA. For instance, Complex II is exclusively encoded by nuclear 
DNA (Koopman et al., 2013, Reinecke et al., 2009, Smeitink et al., 2001). 
MitoNEET (CISDl) 
Background 
MitoNEET was discovered as the target protein of anti-diabetic drug pioglitazone 
(Colca et al., 2004). Localized primarily to the outer membrane of the mitochondria, 
mitoNEET is an iron-sulfur cluster protein that is postulated regulates cellular metabolic 
homeostasis such as mitochondrial iron homeostasis, electron transport and oxidative 
phosphorylation (OXPHOS) (Tamir et al., 2014, Sohn et al., 20 13, Wiley et al., 2007). 
While the exact cellular function(s) of mitoNEET is/are unknown, regulating redox 
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reactions in the mitochondria, the accumulation of reactive oxygen species, and control of 
apoptosis are a few of the proposed functions (Geldenhuys et al., 2014). Reduced 
mitoNEET levels are associated with enhanced mitochondrial iron content, increased 
respiration, and reduced weight gain in mice on high fat diets. Increased oxidative stress 
and glucose intolerance are associated with reduced levels of mitoNEET (Kusminski et 
al., 2012). 
Structure of mitoNEET 
The protein mitoNEET contains a redox-active iron-sulfur ([2Fe-2S]) cluster in a 
CDGSH binding domain. The term "mitoNEET" was given based on its close association 
with the mitochondrion (mito) and its conserved amino acid sequence Asn-Glu-Glu-Thr 
(NEET) (Colca et al. 2004). MitoNEET is a small protein composed of only 108 amino 
acid residues with a molecular weight of 12.2 kDa. The theoretical isoelectric point (pl) is 
9.20 (ExPASy 2015) MitoNEET contains 12 negatively charged residues (Aspartic acid 
and Glutamic acid) and 17 positively charged residues (Arginine and Lysine). The 
computed instability index (II) of 40.55 indicates mitoNEET is an unstable protein, which 
is also supported by the estimated half-life time of 30 hours (for mammalian 
reticulocytes), >20 hours (for yeast, in vivo) and >10 hours in vivo (for Escherichia coli, 
expressed heterologously) (ExPASy 2015). MitoNEET belongs to the CISD (CDGSH 
iron-sulfur domains) protein family. MitoNEET is attached to the outer mitochondrial 
membrane by a N-terminal hydrophobic transmembrane helix and the C-terminal 
hydrophilic CISD domain is facing the cytoplasm (Wiley et al., 2007). The CDGSH 
domain is a type of zinc finger domain which binds iron rather than zinc as a redox-active 
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[2Fe-2S] cluster. Recent reports have indicate that Zn2+ and Fe2+13+ compete for the same 
Zn-finger motif in mitoNEET (Tan et al. 2012). 
In humans, there are three CISD proteins present named mitoNEET (CISDl), 
Miner 1 (CISD2) and Miner2 (CISD3) and they are characterized by presence of one or 
two CDGSH motifs. CDGSH is a domain of around 40 aa (amino acids 55-93) annotated 
as a CDGSH-type zinc finger with a motif containing a highly conserved 17 amino acid 
residue consensus sequence WCXCXX(Sff)XXXPWCDG(Sff/A)H], where W and X 
are a hydrophobic or any residue, respectively. The function(s) of all CISD proteins are 
still ill-defined (Wiely et al 2007, Lin et al 2011). The redox-active 2Fe-2S cluster is pH 
labile and is significantly less stable at pH 4.5 and below when compared to pH 7 .0 
(Tirrell et al., 2009). 
Crystal structures of mitoNEET 
The human mitoNEET forms a homodimer in the crystal structure. Each 
monomer consists of one redox active [2Fe-2S] cluster. Each Fe2+t3+ ion in the clusters is 
tetrahedral and coordinated with the ligand, a sulfide ion and two amino acid residues, 
cysteine and histidine. MitoNEET and other NEET proteins contain two domain 
structures, a cap and a cluster-binding domain (Fig. 2). They are formed by the interlock 
of each monomer forming a homodimer and their unique folding domain called NEET 
fold. Both structural features play vital roles in harboring the redox-active 2Fe-2S cluster 
(Nechushtai et al., 2012). Although other configurations are known, the redox active 
[2Fe-2S] clusters in CISD proteins might be either ferredoxin or Rieske type 
configurations. In the ferredoxin configuration, two cysteine sulfur atoms bind to a Fe2+t3+ 
ion [(Cys)(Cys)FeS2Fe(Cys)(Cys] (Fig. 2). 
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The Rieske-type is characterized by two cysteine sulfur, one Fe2+13+ ion, and the 
Nb atoms of two histidine ligands bind to the other Fe2+13+ ion, 
(His)(His)FeS2Fe(Cys)(Cys) . MitoNEET has unique (Cys)(His)FeS2Fe(Cys)(Cys) 
configuration where, as in Rieske centers , Nb nitrogen of the histidine binds to the cluster 
(Fig. 2) (Dicus et al . 20 1 0). 
A 
B C77., ...... C47 
Fe . 
c 
sf:ts 
C39 - C44 
H15P, Fe Hl34 
ClSl 5�.,._ C132 
D 
Figure 2. Redox active [2Fe-2S] cluster (Hou et al. 2007). Unlike ferredoxin (B) and 
rieske (C), mitoNEET has unique 2Fe-2S cluster bound with three Cys residues and one 
His residue (A) , MitoNEET crystal in a dimer (Lin et al. 20 1 1 ) .  Each monomer (dark and 
gray) consists of p -P-u-P (C to N terminal) topology and a Zn-finger loop binding an 
Iron ion and Sulfur ligand (dark circle) . The respective P-sheets of two monomers are 
anti-parallel to each other (D) 
The amino acid residues in the C-terminal part up to Lys-55 form a P-P-u-P 
topology (Figure 2). However, the N-terminal part from Arg-33 to Lys-55 fom1s a long 
loop. The loop between P2 and al binds a [2Fe-2S] cluster and is flanked by the a-helix 
and two anti-parallel �-sheets (�2 and P3) (Fig. 2) . The Pl region consists of hydrophobic 
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amino acid residues such as Ile-56, Phe-60, Ala-69, Tyr-71, Phe-80, and Phe-82. The 
hydrophobic residues interact with the cluster-binding domain (residues from P2 to P3) 
(Hou et al. 2007). 
A very tight dimerization is created by the multi-hydrophobic interaction between 
different residues of the two associated monomers. (Hou et al. 2007) The amino acid 
residues participating in the dimerization are Val-56 and Val-57 from pl, Leu-65 from 
loop between Pl and p2, Tyr-71 from p2, Trp-75 from the loop between P2 and al, Leu-
101 and Ile-103 from p3. The hydrophobic residues contribute to the dimerization of 
mitoNEET that covers 30% of the total surface area in each monomer. Around 58% of 
amino acid residues participate in the dimerization process. During dimerization, the p 1 
strand of the first monomer, residing in the N-terminal end, forms a parallel P-sheet with 
the P3 strand of second monomer resulting in a "face to face" arrangement of two 
symmetric 3-stranded beta-sheets (Hou et al. 2007). 
Crystal structure of related proteins 
The protein At5g51720 (Arabidopsis thaliana) when truncated from amino acid 
39 to 108 has biochemical and biophysical properties comparable with human mitoNEET 
such as color, absorption peaks in the visible range (at 458 and 530 nm), shift in peaks 
after reduction (at 440 and 550 nm), etc.. The high level of sequence similarity and 
various identical biochemical and biophysical properties of At5 g5 l 720 protein 
demonstrate the occurrence of NEET proteins in plants (Nechushtai et al. 2012). In 
addition, At5g51720 contains the mitoNEET type of 2Fe-2S cluster, coordinated by a 
(Cys)(His)FeS2Fe(Cys)2 ligand, in the CDGSH domain. However, unlike the N-terminal 
transit sequence in human mitoNEET, At5 g5 l 720 contains a cleavable N-terminal leader 
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sequence for the stroma of chloroplast and the mitochondria. The peptide cleavage site of 
At5g51720 transit for chloroplast is V-[R/K]!A-E (Su et al. 2013). 
Thesis Objective 
Recent studies show that mitoNEET plays an important role in mitochondrial 
respiration, but little is known regarding the impact of different levels of mitoNEET on 
cellular respiration, cell proliferation rate and cellular energy transduction. The purpose 
of this study was to elucidate probable role of mitoNEET in liver cancer cells (HepG2 
cells) and its ligand pioglitazone on galactose-induced alteration in cellular bioenergetics. 
9 
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CHAPTER ONE 
D-GALACTOSE DECREASES MITONEET (CISD l )  LEVELS IN HEPG2 CELLS 
ABSTRACT 
Supra-physiological levels of D-galactose accelerate aging in rodents by 
increasing the production of reactive oxygen species (ROS).  However, the underlying 
mechanism of galactose action is still poorly resolved. Similar to galactose treatment, 
mitoNEET deficiency decreases iron content in the mitochondrial matrix and increases 
mitochondrial ROS production. MitoNEET is a small iron-sulfur cluster containing 
protein localized to mitochondrial membranes and was discovered as a target protein of 
the drug pioglitazone. Pioglitazone, an antidiabetic drug, also ameliorates galactose 
mediated aging processes, such as memory deficits and decreased motor activities in a 
mouse model of aging. To investigate the role(s) of mitoNEET in galactose-induced 
aging, we exposed human hepatocellular carcinoma cells (HepG2) to 1 0  mM D-galactose 
and measured endogenous mitoNEET levels by immunoblotting. Galactose treatment for 
2 weeks significantly reduced mitoNEET levels. This effect was observed both in 
presence or absence of glucose in the culture medium. D-galactose also decreased 
mitoNEET tagged with green fluorescent protein (mNT-GFP) levels in stably transfected 
HepG2 cells under the control of the human cytomegalovirus (CMV) promoter. 
Furthermore, treatment of HepG2 cells with 60 µM pioglitazone significantly reduced 
mitoNEET levels similar to D-galactose but at low concentration increased protein 
concentrations. Since the synthesis of endogenous mitoNEET and mNT-GFP are 
regulated by different promoters, D-galactose most likely increases degradation rates of 
mitoNEET. Immunoblotting revealed higher mitoNEET levels in synaptosomes isolated 
17 
from aged mice compared to their younger counterparts. This report highlights the links 
mitoNEET to a D-galactose induced model of accelerated aging. 
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INTRODUCTION 
Galactose mediated aging models: Impact of pioglitazone 
Peroxisome proliferator-activator receptor gamma (PPARy) is a transcription 
factor which include 48 transcription factors . The activity of PPARy is regulated by 
direct binding of lipid metabolites ,  hormones such as steroid and 
thyroid, xenobiotics and vitamins (Kersten et al . ,  2000). Several 
target genes that PPARy stimulate such as genes encoding 
lipoprotein lipase, fatty-acid transport protein, oxidized LDL 
receptor 1 play a role in metabolic homeostasis including 
D-glucose 
increased insulin sensitization and lipid circulation thereby 
lowering glucose, differentiation and maturation of adipocytes . 
Likewise, PPARy stimulation is associated with increased food 
intake in brain and increased antigen uptake in dendritic cells 
D-galactose 
(Brunmair et al, 2004, Knouff and Auwerx 2004, Willson et al. ,  200 1 ,  Lehmann et al. ,  
1 995 and Wiley et al, 2007) .  
The PPARy agonist thiazolidinedione (TZD) family members, pioglitazone for 
example, induce the PPARy coactivator 1 -alpha (PGC- l a) (Hondares et al. ,  2006). 
Transcriptional co-activators PGC- l a, PGC- l P  
and PGC- 1 -related co-activator (PRC) are the 
members of PPAR-y coactivators- 1  (PGC- 1 ) .  
These co-activators have a vital role in Pioglitazone 
maintaining cellular metabolic activities including carbohydrate and lipid metabolism, 
reactive oxygen species homeostasis and energy homeostasis.  Furthermore, the 
1 9  
antioxidant proteins glutathione-peroxidase (GPX), superoxide dismutase (SOD) and 
catalase (CAT) also belong to the PGC- 1 family (Salem et al. ,  20 1 2, Hondares et al. ,  
2006). Pioglitazone, a glucose lowering drug in type II  diabetic patients , has been found 
to bind mitoNEET (Colca et al. ,  2004) as well as reduce mitochondrial activity by 
inhibiting complex I activity in liver tissue and skeletal muscle tissue (Garcia-Ruiz et al. ,  
20 1 3 ,  Sanz et al. ,  20 1 1 , Tait and Green 2010,  Rabf,'Sl et al. ,  20 1 0) .  
Aging i s  characterized by  reduced mitochondrial function, stress intolerance, 
decline of anatomical integrity and function of tissue and organ systems. Although, the 
mechanism of these processes is still unknown, genetic and environmental factors trigger 
aging (Semba et al. ,  20 1 0, Sabin 20 1 0) .  According to the metabolism theory, aging is the 
consequential phenotype of a metabolism disorder of the body (Tang and He 20 1 3) .  
Similar to biological aging and various age-related neurodegenerative diseases, long term 
exposure of D-galactose induces progressive mitochondrial dysfunctions, and to a decline 
in learning and memory capacity in a rodent model (Lei et al. 2008,  Song et al. ,  1 999) but 
the mechanism of this toxicity is unknown. 
A reducing sugar such as D-galactose elevates advanced glycation end-products 
(AGEs) in animal cells and tissues (Schalkwijk et al. ,  2004, Semba et al. ,  20 10,  Singh et 
al. ,  200 1 ,  Song et al. ,  1 999) . The carbonyl group of galactose reacts with primary amino 
groups of proteins, and due to glycoxidation and auto-oxidation, highly reactive carbonyl 
compounds such as carboxymethyl-lysine and hydroimidazolone are formed. These 
reactive carbonyl compounds react with lipids, nucleic acids and proteins forming a 
group of heterogeneous macromolecules, the AGEs (Schalkwijk et al. ,  2004, Singh et al. ,  
2001 ) .  An elevation of AGEs levels in cells is  responsible for a significant glucose 
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metabolism disorder, increase in reactive oxygen species (ROS) and thereby causing 
abnormal metabolism of tissues and organs including heart, liver, kidney, brain and other 
important organs. Furthermore, galactose is reduced into galactitol and increases lipid 
peroxidation, damage cell membranes leading to an acceleration of aging (Semba et al. ,  
20 10,  Song et al. ,  1 999) . Therefore, galactose has been used as a tool to study accelerated 
aging, oxidative stress, and tissue damage in animal models (Tang and He 201 3 ,  
Parameshwaran et al. ,  20 1 0, Song et 
al. ,  1 999) . 
Although the mechanism is 
unknown, the consequence of 
binding of pioglitazone to 
mitoNEET along with PPARy 
stimulation plays a protective role 
against galactose induced aging in a 
rodent model (Prakash and Kumar 
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Figure 3 .  Advance glycation end product 
(AGE) formation with galactose, an overview 
20 1 3 ,  Hunter et al. ,  2008).  To investigate the involvement of mitoNEET in aging 
processes , we measured mitoNEET levels in HepG2 cells exposed to galactose and in 
synaptosomes isolated from young and old mice brains. 
2 1  
METHODS 
Chemicals 
All chemicals for respiration measurements were purchased from Sigma-Aldrich 
(St. Louis, MO) or Fisher Scientific (Fair Lawn, NJ) .  Water for solution preparation was 
purified with a Milli-Q Reagent Water System (Billerica, MA) to an electrical resistance 
of 1 8  mn. 
Cell Culture 
Human hepatocellular carcinoma cells (HepG2) were obtained from the American 
Type Culture Collection (Manassas, VA) and grown in 75 cm2 cell culture flasks 
(Coming Incorporated, Coming, NY) . Standard cell culture medium was composed of 
Opti-MEM I reduced serum medium (lnvitrogen, Carlsbad, CA) supplemented with 5 .5% 
fetal bovine serum (FBS) purchased from Atlanta Biologicals Inc. (Flowery Branch, GA),  
1 00 units/ml penicillin, 100 µg/ml streptomycin, and 250 ng/ml amphotericin B (MP 
Biomedicals, Santa Anna, CA) . Treatment groups were switched to DMEM (Dulbecco's 
Modified Eagle Medium) supplemented with 10 mM D-galactose, 1 5  mM glucose, and 
both 1 0  mM D-galactose and 1 5  mM galactose at least two weeks prior to 
experimentation. Dialyzed FBS was used for 0 mM glucose treatment. The cells were 
maintained in a humidified atmosphere of 6.5 % C02 and 93 .5% air at 37 °C and the 
culture medium was renewed every 3-4 days. The cells were sub-cultured every seven 
days or before reaching -90% confluency. To sub-culture, cells were dissociated using 
0.25% trypsin plus 1 mM EDTA in balanced salt solution (lnvitrogen, Carlsbad, CA) and 
reseeded at 1 .5 x 106 cells per 75 cm2 cell culture flasks . 
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Cloning, transfections and generation of stable cell lines 
pCMV6-AC-GFP (RC203308Ll ) (OriGene Technologies, Inc, Rockville, MD 
20850) vector was used to generate green fluorescent protein tagged mitoNEET cell lines 
(HepG2-mNT-GFP) . The protocol for transfection of HepG2 cells grown in 2500 µL of 
medium in 35 mm dishes using a FuGENE®HD:DNA ration of 4.5: 1 was followed to 
generate the cell line. Briefly, HepG2 cells were plated a day prior to transfection at a 
density of 80% per well in a 35 mm dish in 2 ml of complete growth medium (DMEM + 
1 0% FBS) .  DNA solution at the concentration of 2.5 µg per well was added after mixing 
DNA and reagent (FuGENE®HD) at the ratio of 4.5:1 in 1 25 µL of medium. The 
transfected cells were selected using neomycin (G4 1 8) .  
Impact of galactose and glucose on mitoNEET levels 
SDS-PAGE and Western blotting techniques were used to study the impact of 
galactose and glucose on mitoNEET levels. Proteins isolated from HepG2 cells and 
HepG2-mNT-GFP cells cultured in DMEM supplemented with D-galactose, D-galactose 
with dialyzed FBS ,  glucose and both galactose and glucose were used. Proteins were 
isolated from -5x 106 cells of the respective treatment groups using RIPA buffer (25mM 
Tris-HCI pH 7 .6, 1 50mM NaCl, 1 % NP-40, 1 % sodium deoxycholate, 0 . 1 % SDS) 
following the manufacturer' s  protocol (Thermoscientific # 89900) and the protein 
concentration was determined using Thermo Scientific, Pierce™ Coomassie (Bradford) 
Protein Assay Kit according to the instructions of the manufacturer (Thermo Fisher 
Scientific, Waltham, MA) . 
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Synaptosome Isolation from mouse brain 
Brain synaptosomes from young (3-6 months) and old ( 1 2+ months) female WT 
(C57BU6J) littermate mice were used in this study. Synaptosomes were isolated by Eric 
Hendricks for his thesis work as described by Kristian (20 1 0) with minor modification 
and kindly provided to us (Hendricks 20 15 ,  Master' s Thesis) . Briefly, the forebrain was 
removed, washed, and homogenized in 20 mL of isolation medium (IM) containing 
sucrose (225 mM), mannitol (75 mM), EGTA ( 1  mM), HEPES (5 mM), and 1 g/L BSA 
adjusted to pH 7.4 with Tris base. The homogenate was transferred evenly into two 1 0  
mL polycarbonate tubes and centrifuged at 1 300g for 3 min. The pellet was resuspended 
in 3 mL of IM and centrifuged at 1 300g for an additional 3 min. The supernatants from 
the two centrifugations were combined and centrifuged at 2 1 ,000g for 1 0  min. A Percoll 
gradient in IM was prepared in a separate polycarbonate tube by first adding 3 .7 mL of 
24% Percoll and, using a transfer pipette, 1 .5 mL of 40% Percoll was slowly added 
underneath the 24% Percoll layer. The supernatant from the previous centrifugation step 
was discarded and the pellet was re-suspended in 3 .5 mL of 15% Percoll, and the re­
suspended pellet was next layered on top of the 24/40% Percoll gradient using a transfer 
pipette, and then centrifuged at 30,700g for 8 min. The material at the 1 5 %  Percoll band, 
containing mostly myelin, was discarded, whereas the 24% Percoll band, containing 
mostly synaptic mitochondria, was collected. The fraction containing the synaptosomes 
was washed with 6 mL of IM and centrifuged at 1 6, 700g for 1 0  min. This step was 
repeated and the supernatant was discarded both times .  The resulting pellet was re­
suspended in 400 µL of IM and contained 6-7mg/mL synaptosomal protein, which was 
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determined using a Percoll friendly Modified Lowry Protein Assay Kit according to the 
instructions of the manufacturer (Thermo Fisher Scientific, Waltham, MA). 
SDS-PAGE and Western blot analyses. 
Isolated proteins were subjected to 12% SDS-PAGE using a Bio-Rad Mini­
PROTEAN 3 Cell (Bio-Rad Laboratories, Hercules ,  CA). Proteins were denatured at 
96°C for 5 min in sample buffer (2% SDS, 25% glycerol, 5 %  P-mercaptoethanol, 0.0 1 % 
bromphenol blue, and 62.5 mM Tris-HCl, pH 6 .8) ,  and 1 5-20 µg of protein were loaded 
per lane. After electrophoresis, proteins in the gel were electrophoretically transferred 
onto a nitrocellulose membrane (0.2 mm, Bio-Rad) in a transfer buffer ( 1 92 mM glycine, 
20% methanol, 0.025% SDS, and 25 mM Tris) by use of a Bio-Rad Mini Trans-Blot. 
Membranes were stained with Ponceau S (Sigma-Aldrich 0. 1 % v/v glacial acetic acid, 
0 .0 1 1 % w/v Ponceau S) to confirm transfer of the proteins . The nitrocellulose membrane 
was blocked using blocking buffer (5% w/v milk powder in TBS-T, 20 mM Tris-HCl, pH 
7 .6, 1 37 mM NaCl and 0. 1 % Tween-20) for 1 hour. Anti-CISD l [2B3] mouse 
monoclonal antibody (ab 1 1 8027), rabbit polyclonal antibodies anti-VD AC antibody (Cell 
Signaling, #D73 1 2) ,  anti- P-tubulin (Cell Signaling, #2 1 28S) and anti-P-actin antibody 
(Cell Signaling, #4967S)  were used as primary antibodies at 1 : 5 ,000 dilutions. The blots 
were incubated overnight with the primary antibody in blocking buffer at 4 °C. 
Biotinylated goat anti-rabbit IgG and goat anti-mouse IgG (Vector Laboratories) were 
used as secondary antibodies at dilutions of 1 :5 ,000. Blots were stained and developed 
using Amersham Hyperfilm ™ (GE healthcare Ltd, #28906837) and LumiGLO (Cell 
Signaling Technology, Danvers , MA #7003) ,  following the protocol of the manufacturer. 
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Western Blotting band analysis 
ImageJ (imagej .nih.gov/ij/ National Institutes of Health) open access software 
was used to analyze the band intensities. The bands intensities were expressed in terms of 
percentage of a cellular housekeeper and/or a mitochondrial housekeeper protein (P­
tubulin, P-actin and/or VDAC). 
Statistical Analysis 
Student t-test using Microsoft excel was used to analyze Western blot data. A 
stepwise multiple comparisons procedure (Newman-Keuls method) was used to 
identify sample means that are significantly different from each other. 
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RESULTS 
D-galactose decreased cellular mitoNEET levels in HepG2 cells 
HepG2 cells were grown in DMEM supplemented with 1 0  mM galactose for two 
weeks . The two proteins P-actin and VDAC were chosen as cellular and mitochondrial 
housekeeper proteins , respectively. Western blotting showed galactose treatment 
significantly reduced mitoNEET levels to 29 .4 ± 2. 1 6  % of p actin from 42.73 ± 4.28 % 
of p actin in high glucose medium (Fig. 4) .  To investigate whether galactose or glucose is 
responsible for the altered levels of mitoNEET, we used a low glucose medium and 
supplemented with 1 5  mM glucose alone, 1 0  mM galactose alone or the combination of 
1 5  mM glucose plus 1 0  mM galactose. Western blotting showed galactose decreased the 
mitoNEET levels irrespective of presence of the glucose and band intensities of 45 .8  ± 
5 .35 % of controls were found in samples cultured in 1 0  mM galactose alone, 72.6 ± 4.37 
% of controls in 15 mM glucose and 10 mM galactose together (Fig. 5) .  No changes in 
the amount of VDAC or P-actin (Fig. 4 and Fig. 5 )  were found among the treatment 
groups verifying that both proteins are suited to serve as housekeeper proteins . 
Furthermore, the results support the interpretation that mitoNEET levels per 
mitochondrion were decreased due to galactose treatment and not as a result of reductions 
in mitochondrial quantity per cell. 
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(B) Band intensities were quantified using ImageJ software (p < 0.05 ,  n = 4, ± 
SEM). *statistically significant differences between different treatment groups. 
A 
VI 
al u.. 
:l - "C 
G ro QJ l!) N 
+ + �  ro 
� � :c 
UJ UJ ..c � � .� 
Cl Cl 3: 
:l 
G 
+ 
n; n; l!) l!) 
+ + 
:!! � 
I.LI UJ 
� � 
Cl Cl 
B 
VDAC 
mito N E ET 
120 � 
0 
DMEM+Glu OMEM+Gal OMEM+Gal+Glu 
(Controls) 
Figure 5 :  Galactose, not glucose, is responsible for altered endogenous mitoNEET levels. 
(A) Western blot showing mitoNEET levels in HepG2 cells cultured in 1 0  mM galactose 
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Band intensities were quantified using ImageJ software (p < 0.05 , n = 3 ,  ± SEM). () 
indicate statistically significant differences between different treatment groups. 
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D-galactose likely targets degradation of cellular mitoNEET in HepG2 cells 
The synthesis of cellular mitoNEET is endogenously regulated by cisdl gene 
located on chromosome 1 0  (Tamir et al. ,  20 1 5 ,  http://www.ncbi .nlm.nih.gov/gene/55 847) 
HepG2 cells were stably transfected with a chimeric protein composed of green 
fluorescent protein (GFP) attached to the C-terminus of mitoNEET (mNT-GFP). 
Transcription of the construct was under the control of the human cytomegalovirus virus 
(CMV) promotor. After stable clones were obtained, the mNT-GFP cells were cultured in 
low glucose medium supplemented with 1 0  mM D-galactose for two weeks . Similar to 
the levels of endogenous mitoNEET in control HepG2 cells (Fig. 5 ) ,  the galactose 
treatment significantly reduced the endogenous mitoNEET levels to 75 .2 ± 2.4 % of 
controls in GFP-mNT-GFP cells .  Surprisingly, not only were the endogenous mitoNEET 
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Figure 6 :  Galactose targets degradation of mitoNEET. Western blot showing 
endogenous mitoNEET, as well as green fluorescent protein tagged mitoNEET (mNT-
GFP) levels in HepG2-mNT-GFP cells cultured in galactose or glucose supplemented 
medium. Galactose reduced both endogenous as well as mNT-GFP. Band intensities 
were quantified using ImageJ software (p < 0.05 , n = 3, ± SEM). 
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levels reduced, but galactose also lowered the levels the chimeric protein mNT-GFP to 
52.7 ± 9 .39  % of controls (Fig. 6), suggesting that galactose increases degradation rates 
of mitoNEET. 
Time course of mitoNEET degradation 
HepG2 cells maintained in high glucose medium were transferred to the medium 
supplemented with 1 0  mM D-galactose and the levels of endogenous mitoNEET were 
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Figure 7 :  D-galactose mediated degradation of mitoNEET increases over time. (A) 
Western blot showing mitoNEET levels in HepG2 cells after switching the medium 
glucose to galactose (B) Band intensities were quantified using ImageJ software (p < 
0.05 , mean ± SEM),  curve is only for the illustration purpose. 
measured every other day for two weeks . Western blotting shows galactose significantly 
reduced endogenous mitoNEET levels in two weeks compared to the controls (Fig. 7) .  
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Pioglitazone at high concentration reduces but at low concentration partially 
restores mitoNEET 
HepG2 cells cultured in high glucose medium or in presence of 1 0  mM galactose 
supplemented medium were treated with different concentration of pioglitazone for 24 h. 
Again, � actin and VDAC were used as cellular housekeeper and mitochondrial 
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Figure 8. Pioglitazone reduces mitoNEET levels at high concentrations, but restores 
protein levels at low concentrations . Western blot showing mitoNEET levels in 
HepG2 cells treated with different concentration of pioglitazone (pio) cultured in (A) 
1 0  mM galactose and (B) high glucose medium. Band intensities were quantified 
using ImageJ software. 
housekeeper proteins, respectively. Western blotting revealed pioglitazone at a 
concentration of 60 µM significantly reduced endogenous mitoNEET levels similar to 
D-galactose but at 7 .5 µM and 1 5  µM partially restored endogenous mitoNEET levels in 
both high glucose and galactose supplemented mediums (Fig. 8) .  
MitoNEET expression is  elevated in the synaptosomes of aged mice 
Synaptosomes (mitochondria located in neuronal cell tenninals) were isolated 
from the forebrain of young (3-4 month old) and old (more than 1 2  months old) mice . 
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The endogenous mitoNEET levels were measured using the Western blotting technique. 
Two proteins which are synthesized regularly in the cells W-actin and �-tubulin) were 
used as control for cellular housekeeping proteins and the outer mitochondrial protein 
VDAC, served as control for a mitochondrial housekeeping protein. Western blotting 
showed significant increases in endogenous mitoNEET levels in aged mice compared to 
the young counterparts (Fig. 9) .  
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Figure 9.  Old mice express higher mitoNEET levels in brain. (A) Western blot showing 
mitoNEET levels in synaptosomes of young and old mice. (B) Band intensities were 
quantified using ImageJ software (p < 0.05 ,  young n = 4, old n = 3 ,  ± SEM). 
*statistically significant differences between young and old group of mice. 
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DISCUSSION 
The results of this study document that exposure of HepG2 cells to galactose 
decreased endogenous mitoNEET levels and the level of the chimeric protein mNT-GFP. 
Furthermore, treatment of hepatocytes with pioglitazone, which binds to mitoNEET, also 
reduced endogenous mitoNEET levels at high concentration but restored galactose 
induced reductions in endogenous mitoNEET levels at low concentration. 
Recent studies suggest that, similar to mitoNEET knockdown experiments, 
chronic administration of galactose facilitates the aging process by increasing oxidative 
stress, mitochondrial injury and advanced glycation end products (AGE) in vivo 
(Parameshwaran et al. ,  20 1 0, Semba et al. ,  20 1 0, Song et al. ,  1 999) . Decreases in 
mitoNEET levels in HepG2 cells cultured in D-galactose (Fig. 5) might be an example of 
glycation and degradation or a feedback mechanism to control increased mitochondrial 
activity due to relief of the Crabtree effect (see Chapter 2) (Crabtree 1929). Pioglitazone 
partially restored mitoNEET levels (Fig. 8) ,  perhaps by inducing PGC l a  expression and 
counteracting galactose-induced increased respiration by inhibiting complex I and 
playing a protective role against galactose-induced aging observed in a rodent model 
(Prakash and Kumar 20 1 3 ,  Kaundal and Sharma 2010,  Hunter et al. ,  2008) .  Pioglitazone 
also plays a protective role against D-galactose-induced mitochondrial oxidative damage 
and apoptosis through activation of nuclear transcription factor PP ARy receptors 
(Prakash and Kumar 201 3) .  Increased ROS production, oxidative damage and 
mitochondrial dysfunction are the characteristic features of aging. We observed 
synaptosomes isolated from aged group of mice have higher mitoNEET levels (Fig. 9) .  
Overexpression of mitoNEET might be the positive feedback mechanism of 
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overexpressed PGCla to reduce progressively increased ROS levels down thereby 
protecting cells and organelles . 
In conclusion, results suggest that mitoNEET plays a role in biological as well as 
galactose increased aging, which may be due to decreased mitoNEET levels thereby 
increasing ROS levels in the cells. Increases in ROS levels as a results of mitoNEET 
knockdown and galactose treatment should be evaluated in a rodent model using liver 
tissues or in the HepG2 cell model. Pioglitazone partially restored galactose induced 
decreases in mitoNEET levels and perhaps suggests that this might ameliorate galactose 
toxicity in the cells . Biological aging and galactose induced aging likely utilize distinct 
mechanisms in terms of mitoNEET effects . 
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CHAPTER TWO 
THE EFFECTS OF PIOGLITAZONE ON LIVER CELL BIOENERGETICS 
ABSTRACT 
Insulin resistance is linked to mitochondrial dysfunction and decreased oxidative 
capacity of metabolically active tissues. Pioglitazone is commonly used to treat type-II 
diabetes and has been shown to interact with mitoNEET {mNT, CISD l )  which localizes 
to the mitochondrion. We recently observed that human hepatocellular carcinoma cells 
(HepG2) cultured in presence of D-galactose ( 1 0  mM) at low glucose concentrations (<l 
mM) express significantly reduced levels of mitoNEET compared to cells cultured in 
presence of glucose alone. We hypothesized that since galactose and pioglitazone alter 
cellular mitoNEET levels, significant changes in cellular bioenergetics may occur. We 
employed respirometry and calorimetry to investigate the effects of mitoNEET levels on 
cellular bioenergetics after galactose and pioglitazone treatment in HepG2 cells. 
Respiration rates of permeabilized cells in the presence of mitochondrial substrates 
(malate, glutamate plus pyruvate) utilized by complex I and ADP (OXPHOS) were 
significantly increased for HepG2 cells cultured in galactose (45 . 8  ± 1 .96 pmol 02 . s- 1 • 
1 0-6 cells ; n = 6, ± SE) compared to cells cultured in 1 5  mM glucose alone (30.5 ± 2.94 
pmol 02 · s- 1 · 10-6 cells ; n = 6, ± SE) . Acute exposure to 60 µM pioglitazone caused a 
severe reduction in OXPHOS for cells cultured in either medium (galactose: 1 2. 1 8  ± 1 .37 
pmol 02 · s- 1 • 10-6 cells ; glucose: 10 . 1 ± 1 .0 1 pmol 02 · s- 1 • 10-6 cells) . 
Overall heat flow of intact cells was -55 .6 ± 3 .0 µW per million cells in glucose 
medium and metabolic activity was significantly reduced to -47 .2 ± 2.5 µW per million 
cells (n = 10,  ± SE) in cells cultured in the presence of galactose. Surprisingly, acute 
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treatment of cells with 60 µM pioglitazone increased heat dissipation in cells grown in 
glucose medium by -20%, but the effect was significantly lower for cells cultured in the 
presence of galactose. Transfection of HepG2 cells with green fluorescent protein tagged 
mitoNEET (HepG2-GFP-mNT) increased respiration rates and heat flow in either 
glucose or galactose media. Our results demonstrate that pioglitazone targets complex I 
of the mitochondrial OXPHOS machinery, but the decrease in mitochondrial efficiency is 
likely compensated by an increase in glycolytic flux. 
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INTRODUCTION 
Diabetes related complications are the primary cause of death in the USA. In 
20 12, 29. 1  million Americans or 9 .3% of the total population have been diagnosed with 
type II diabetes. Even more strikingly, 1 1 . 8  million or 25 .9% of elderly people above the 
age of 65 years have diabetes (National Diabetes Statistics Report, 20 14) .  The American 
Diabetes Association (ADA) states that diabetes caused 23 1 ,404 deaths as listed on the 
death certificates in 20 1 3  (ADA). Pioglitazone (brand name 'Actos ' ) ,  PPARy agonist, is 
used to increase the response of cells to the blood-sugar regulating hormone insulin 
(peripheral tissue insulin sensitivity), and to inhibit the release of blood sugar (glucose) 
from the liver in type-2 diabetes (Miyazaki 2002) . Recent studies demonstrated that 
pioglitazone also binds to mitoNEET and addresses the underlying cause of type-2 
diabetes through increasing deposition of fat (lipids) in fat cells termed adipocytes 
(Kusminski et al. ,  20 12 ,  Colca et al. ,  2004) . 
The biological function(s) of mitoNEET are still unknown, but the proposed 
functions include donation of the iron-sulfur cluster to unknown acceptor protein(s) and 
functioning as electron transfer protein. Regulation of redox reactions and oxidative 
phosphorylation (OXPHOS) in the mitochondria, accumulation of reactive oxygen 
species (ROS) and control of apoptosis are also the proposed functions of mitoNEET 
(Tait and Green 201 0, Wiley et al. ,  2007, Kaundal and Sharma 20 1 0) .  Transfer of unique 
iron-sulfur cluster of mitoNEET is decisive for mitoNEET functioning (Tamir et al. ,  
20 14, Wiley et al. ,  2007) .  Binding of pioglitazone to mitoNEET has been shown to 
reduce the likelihood of iron-sulfur cluster transfer in vitro (Paddock et al. ,  2007, Wiley 
et al. ,  2007) .  High mitoNEET levels are associated with enhanced mitochondrial iron 
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content, increased respiration rates and reduced weight gain on high fat diet in a mouse 
model of obesity. Similarly, increased oxidative stress and glucose intolerance are 
associated with reduced level of mitoNEET (Kusminski et al. ,  20 1 2) .  
The major function of mitochondria is to generate and supply ATP to the cells in  addition 
to supplying intermediates for several biosynthetic pathways. Furthermore, mitochondria 
are the major producers of cellular ROS . Compromised energy metabolism and 
mitochondrial dysfunction are characteristic features of metabolic diseases like diabetes 
(Kim et al. ,  2008), and neurodegenerative diseases including Alzheimer' s disease and 
Parkinson' s  disease (Swerdlow 2009).  
The efficiency of mitochondrial OXPHOS can be defined as the ratio of ATP 
generated per amount of oxygen consumed (PIO ratio) . A high PIO ratio indicates better 
coupling of the electron transport system (ETS) with the phosphorylation system. 
Decreases in the proton motive force (8p) and increased uncoupling of the OXPHOS 
system leads to waste of redox energy and increases in thermogenesis. Unspecific proton 
leak (LEAK respiration), fatty acids , uncoupling proteins (UCP), calcium uniport, 
adenine nucleotide antiport (ADP/ATP exchange) , phosphate symport (P04-/H+ uptake) ,  
and aspartate/glutamate + H+ exchange are the major mitochondrial membrane potential 
(8 \}Im) consuming processes across the mitochondrial membrane (Kadenbach 2003) 
Experimentally, the state of oxygen consumption by isolated mitochondria after addition 
of different substrate are traditionally categorized into five states ,  designated 1 through 5 .  
State 1 i s  the respiration of mitochondria alone (in presence of Pi) and State 2 includes 
the addition of ADP without exogenous substrate. State 3 includes the ADP-stimulated 
oxygen consumption by intact mitochondria in presence of excess substrate (OXPHOS) 
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respiration and state 4 is carried out in presence of specific mitochondrial substrate 
(malate, glutamate plus pyruvate, succinate and fatty acids) but without ADP or any 
metabolic inhibitors (LEAK) . Lastly, state 5 is the respiration without oxygen. Only 
respirations states 3 and 4 are frequently used when measuring the efficiency of 
mitochondrial OXPHOS . State 3 respiration in presence of substrate plus ADP is often 
denoted by state 3 ADP and in presence of uncoupling reagent is denoted by state 3u 
(Nicholls and Ferguson 20 1 3) .  
The respiration in  response to ADP measures the ability of  mitochondria to 
synthesize ATP and is represented by the mitochondrial respiratory control ratio (RCR) . 
The RCR, the proton leak rate (LEAK), the maximum respiratory rate, and the coupling 
efficiency all provide information about mitochondrial function and dysfunction (Brand 
and Nicholls 20 1 1 ) .  The ratio of state 3/state 4 respiration is known as the RCR. RCR is 
not an absolute value, but depends on the tissue type and substrate. A high RCR value 
indicates better membrane integrity, greater capacity for oxidation of substrate and high 
efficiency in ATP production. State 3 respiration rates depend on the size of cytochrome 
c-ubiquinone (cyt c-UQ) pool, and concentration of available oxygen, whereas proton 
leak and A TPase contamination primarily control state 4 respiration (Nicholls and 
Ferguson 20 1 3) .  Oligomycin A inhibits the ATP synthase (Salomon et al. ,  2000). 
Therefore, a high state 4 respiration rate after addition of oligomycin (state 4o) indicates 
high proton leak in vivo or injury to the inner mitochondrial membrane during the 
isolation process .  A low state 4o indicates high proton motive force (PMF) sufficient 
enough to restrict electron transport (Brand and Nicholls 20 1 1 ) .  PMF (.!\p) is defined as a 
proton circuit across the inner mitochondrial membrane created by proton pumps of ETS 
43 
together with ATP synthase. This energetic force or potential is central to mitochondrial 
bioenergetics which has two components, pH gradient and the membrane potential 
(8.'l'm) between mitochondrial matrix and cytoplasm (eqn 1 )  (Brand and Nicholls 20 1 1 ,  
Nicholls and Ferguson 20 1 3) .  
8.p = L\'l'm - 6 1 .5 log lOL\.pH (Equation 1 )  
Warburg effect and Crabtree effect 
Glucose is a major source of cellular energy. When the cell has an adequate 
supply of metabolic energy available in the form of ATP, the breakdown of glucose is 
inhibited because NADH, generated in the Kreb's  cycle, inhibits isocitrate dehydrogenase 
(EC 1 . 1 . 1 .4 1 )  and a-ketoglutarate dehydrogenase (EC 1 .2.4.2), thus accumulating acetyl 
CoA and lactic acid (Berg et al. ,  2002) . An important aspect of cancer cells is their ability 
to survive under hypoxic and acidic conditions (Marroquin et al. ,  2007) .  Many highly 
proliferative cells, including cancerous cells, depend on glycolysis for ATP generation 
despite the abundance of oxygen and fully functional mitochondria (Warburg effect) , 
likely to increase production of precursors for biosynthetic pathways (Heiden et al. ,  
2009). However, despite the reduction in cellular respiration the mitochondria are not 
impaired, they are just not utilized; this phenomenon was first identified by Otto Warburg 
and was termed the Warburg Effect (Warburg 1 956, Vander et al. ,  2009).  
The phenomenon that some cells, in spite of having fully functional mitochondria 
and abundant oxygen, shift metabolism towards glycolysis in presence of high glucose 
concentrations, is known as the Crabtree Effect (Marroquin et al. ,  2007, Crabtree 1 929) . 
When using immortalized cell lines (cancer cells) as a model to evaluate mitochondrial 
function, it is important to understand the consequences of the Warburg and Crabtree 
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effects . Many mitochondrial toxicants cannot be detected with this cellular model due to 
limited use of the mitochondria in immortalized cells (Vander et al. ,  2009).  However, 
some immortalized cell when grown in galactose medium in the absence of glucose favor 
mitochondrial respiration (OXPHOS) due to relief from the Crabtree effect (Altamirano 
et al. ,  2006) . To elucidate the role of mitoNEET in galactose and pioglitazone induced 
changes in liver cell bioenergetics, we used cellular respirometry and calorimetry. 
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METHODS 
Respirometry of HepG2 cells 
Respiration was measured at 37 °C using l x l06 cells per mL in each chamber of 
the Oxygraph-2K (OROBOROS Instruments, Innsbruck, Austria) . Oxygen consumption 
of permeabilized cells was measured in 2 mL of MiR05 ( 1 10 mM sucrose, 60 mM 
potassium lactobionate, 20 mM taurine, 10  mM KH2P04, 3 mM MgCh, 0.5 mM EGTA, 
0. 1 % BSA, 20 mM HEPES-KOH, pH 7 . 1 ) . In order to supply mitochondrial substrates, 
cells were permeabilized by the addition of digitonin dissolved in Me2SO at 1 0  mg • mL-1 
(final concentration 10 µg • 1 0-6 cells) .  This digitonin concentration was found to be 
sufficient to permeabilize the plasma membrane of HepG2 cells with low impact on the 
integrity of the outer mitochondrial membrane. Electron flow through complex I was 
stimulated by adding 2 mM malate, 1 0  mM glutamate, and 5 mM pyruvate (MGP) . To 
engage the phosphorylation system, 1 mM ADP was added followed by the addition of 
10  mM succinate to supply electrons to the ubiquinone pool via succinate dehydrogenase. 
Leak respiration in presence of ADP and ATP was measured after addition of oligomycin 
(2 µg • mL-1 ) ,  and contribution of complex I to leak respiration was recorded after 
addition of rotenone (0.5 µM) . Non-mitochondrial oxygen consumption was recorded 
after addition of 2.5 µM of antimycin A. Oxygen consumption was measured with an 
Oxygraph-2K (OROBOROS Instruments, Innsbruck, Austria) DATLAB software 
(OROBOROS Instruments) was used for data analysis and acquisition. 
Heat Dissipation 
An LKB 2277 thermal activity monitor (Bromma, Sweden) was used to measure 
the heat dissipation of cells in suspension. Static and dynamic calibrations against water 
46 
in both ampoules were performed before the heat signal was measured. For the biological 
experiments , water in the sample ampoule was replaced with 2.5 ml of cell suspension. 
One ampule was set as the control (DMSO) while the other ampule had 60 µM 
pioglitazone. This total suspension contained between 375 ,000 and 500,000 cells in 
culture medium equilibrated with 1 0% C02 and 90% air. All calorimetric measurements 
were performed at 37 °C. Overall heat flow of intact cells was recorded for 2 hours after 
the ampoule was lowered into the calorimeter. 
Cell proliferation 
The cells were maintained in a humidified atmosphere of 6 .5% C02 and 93 .5% air 
at 37 °C. Cells that were used for proliferation data were also incubated in 1 5 ,  30, or 60 
µM pioglitazone. To assess the cell proliferation rates, 250,000 cells per well were plated 
on a 12-well plate. Different concentrations of pioglitazone were added (0-60µM) after 
24 h that cells were plated. Cells were counted after 24 and 48 h after pioglitazone 
treatment. Viable cells were counted with a hemocytomter using trypan blue exclusion 
by diluting samples in a 1 :  1 ratio with trypan blue. 
Data Analysis 
Data were analyzed with a one-way analysis of variance (ANOV A) on ranks 
followed by comparison of experimental groups with the appropriate control group 
(Holm-Sidak method) or 2-way ANOV A followed by comparison of experimental groups 
with the appropriate control groups (Holm-Sidak method) . SigmaPlot 1 2.5 (Systat 
Software Inc. ,  San Jose, CA) and statistical package R (R version 3 . 1 .2 (2014- 1 0-3 1 )  
were used for the analyses. 
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RESULTS 
Galactose increased OXPHOS activity 
Oxygen consumption rates in the presence of different mitochondrial substrates 
were recorded for permeabilized HepG2 and HepG2-mNT-GFP cells which were prior to 
measurements cultured in galactose supplemented medium or high glucose medium. 
In the presence of NADH generating substrates malate, glutamate and pyruvate 
(MGP) utilized by complex I, HepG2 cells cultured in galactose had significantly lower 
respiration rates (state 4 respiration) compared to controls (HepG2 in glucose) . 
Pioglitazone treatment did not change oxygen consumption rates in either glucose or 
galactose media (Fig. l OA) . Again, in the presence of NADH generating substrates 
(MGP), HepG2-mNT-GFP cells cultured in galactose had significantly higher respiration 
rates compared to their glucose counterparts . Pioglitazone significantly increased state 4 
respirations in HepG2-mNT-GFP cells cultured only in glucose medium (Fig. l OA). 
The addition of ADP to the conditions described in Fig. 1 OA resulted in oxygen 
consumption rates that were significantly increased in both HepG2 and HepG2-mNT­
GFP cells compared to their MGP respiration rates .  These elevated respiration rates were 
significantly higher in galactose treated HepG2 cells compared to their glucose 
counterpart. Elevation of respiration after addition of ADP in HepG2-mNT-GFP cells 
was not significantly different in either medium. However, HepG2-mNT-GFP cells 
cultured in both glucose and galactose media showed significantly higher respiration 
rates compared to HepG2 cells cultured in glucose medium (Fig. l OB) .  
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Figure 10 .  Oxygen consumption of permeabilized HepG2 and HepG2-mNT-GFP 
(mNT) cells cultured in glucose and DMEM plus galactose (Galactose) in response to 
acute addition of 60 µM pioglitazone (gray bar) in the presence of (A) NADH 
generating substrates (MGP) without ADP, (B) MGP plus ADP, (C) MGP, ADP and 
succinate and (D) MGP, ADP and succinate (LEAKo respiration) (n = 6, ± SE) 
Statistically significant differences in pioglitazone treatment (*) ,  differences between 
cell lines in the same medium (') and differences between the media of the same cell 
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Pioglitazone significantly reduced complex I activity 
Oxygen consumption rates were recorded in HepG2 and HepG2-mNT-GFP cells 
after treatment with pioglitazone at the concentration of 60 µM in presence of NADH 
generating substrates (MGP) and ADP. Prior to experimentation, those cells were 
cultured in 1 0  mM D-galactose supplemented medium. Pioglitazone treatment markedly 
reduced oxygen consumption rates of permeabilized HepG2 cells and HepG2-mNT-GFP 
cells cultured in either glucose or in galactose medium. Interestingly, HepG2-mNT-GFP 
cells cultured in galactose were less sensitive to pioglitazone compared to all other 
conditions evaluated (Fig. l OB) .  
Addition of  succinate to the conditions shown in Fig. l OB generate NADH and 
FADH2 utilized by both complexes. The succinate stimulated respiration rates in HepG2 
cells cultured in glucose in presence of MGP and ADP increased by an average of 64.5% 
and that of in galactose medium increased by 45 .6%. Similarly, respiration in HepG2-
mNT-GFP cells cultured in glucose medium increased by 62.2% and that of galactose 
increased by 57 .5%.  Both cell types HepG2 and HepG2-mNT-GFP were treated with 
pioglitazone at the concentration of 60 µM. Strikingly, after treatment with pioglitazone, 
the succinate stimulated respiration rate in presence MGP and ADP increased by 350% in 
HepG2 cells cultured in glucose medium and that of in galactose increased by 83 .3%.  
Likewise, succinate stimulated respiration increased by 3 8 1 .8% in  HepG2-mNT-GFP 
cultured in glucose medium and that of in galactose medium increased by 222.2%. 
Although, succinate stimulated respiration in pioglitazone treated cells increased by an 
average of 259%, this increase is 19 .7% less than the respiration in cells without 
pioglitazone treatment (Fig. l OC).  
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D-galactose and pioglitazone increased stat 4o (LEAKo) respiration 
The addition of oligomycin to the conditions described in Fig. l OC 
(MGP+ADP+succinate) allowed state 4o (LEAKo) respiration to be evaluated. HepG2 
cells and HepG2-mNT-GFP cells cultured in galactose had significantly higher state 4o 
respiration compared to their control counterparts cultured in glucose medium. Both 
HepG2 and HepG2-mNT-GFP cells were treated with pioglitazone at the concentration 
60 µM. Pioglitazone treatment significantly increased state 4o respiration across all 
cultured conditions. Interestingly, pioglitazone treated HepG2 and HepG2-mNT-GFP 
cells cultured in galactose medium had further increased state 4o respiration compared to 
their glucose counterparts treated with pioglitazone (Fig. lOD).  
MitoNEET decreased glutamate dehydrogenase activity after galactose treatment 
Addition of glutamate as the only mitochondrial substrate to permeabilized 
HepG2 cells before uncoupling allows evaluating the activity of glutamate 
dehydrogenase. Interestingly, galactose treatment for 2 weeks prior to respirometry lead 
to a decrease in oxygen consumption in HepG2-mNT-GFP cells compared to respiration 
in HepG2 cells (Fig. 1 l A) .  FCCP (Carbonyl cyanide p- [rifluoromethoxyl] -phenyl­
hydrozone) is a pure uncoupler (an ionophore) which dissipates the chemiosmotic 
gradient leading to loss of regulation of the electron transport system. Maximum 
uncoupled rates of intact cells were obtained using FCCP. A significant increase in 
uncoupled respiration was observed in HepG2 cells cultured in galactose medium. 
However, the uncoupled respiration was significantly reduced in HepG2-mNT-GFP cells 
cultured in galactose compared to their control counterpart cultured in glucose (Fig. 1 l B) .  
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Figure 1 1 . Oxygen consumption of permeabilized HepG2 and HepG2-mNT-GFP 
(mNT) cells cultured in glucose or galactose (A) using glutamate as the sole substrate, 
(B) using glutamate as the sole substrate and uncoupling with FCCP (n = 6, ± SE) 
Statistically significant differences between cell lines in the same medium �) and 
differences between the media of the same cell line (M) . 
Pioglitazone treatment at the concentration of 60 µM did not show significant uncoupled 
respiration in HepG2 cells cultured in either medium glucose or galactose. However, 
pioglitazone treatment significantly increased uncoupled respiration in HepG2-mNT-GFP 
cells cultured in galactose compared to HepG2 cells cultured in similar conditions (Fig. 
1 2). 
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Heat dissipation 
Galactose reduced energy transduction 
HepG2 cells and HepG2-mNT-GFP cells maintained in high glucose medium 
were transferred to low glucose containing medium supplemented with 10  mM galactose 
2 weeks prior to experimentation and heat flow was evaluated. The results revealed that 
galactose significantly reduced the heat output in both the HepG2 and HepG2-mNT-GFP 
cells compared to their control counterparts cultured in glucose medium. 
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Pioglitazone increased energy transduction over time in galactose supplemented 
medium 
HepG2 and HepG2-mNT-GFP cells cultured in high glucose medium and 
galactose medium were treated with 60 µM pioglitazone and heat dissipation was 
monitored every 30 minutes after treatment for 2 hours . Pioglitazone increased heat 
dissipation immediately after treatment (30 min) in HepG2 and HepG2-mNT-GFP cells 
cultured in glucose medium. However, unlike cells cultured in glucose medium, 
pioglitazone treatment did not increase heat dissipation of cells cultured in galactose 30 
min after treatment. However, the heat flow measured 2h after treatment was 
Table 1 :  Cells were cultured and evaluated in either galactose (GAL) or glucose 
(GLU) based medium. Cells were treated with acute addition of 60 µM of 
pioglitazone or DMSO (vehicle control) .  Overall heat dissipation was increased after 
addition of pioglitazone to cells in glucose medium but not for galactose based 
medium (n=8 , ±SE) . 
Condition 30 min 60 min 90 min 120 min 
HepG2 55 .6 ± 3 .00 56.7 ± 2. 1 1  55 .3  ± 2.02 53 .9 ± 2. 1 2  
HepG2 + Pio 65 .5 ± 2.38 62.9 ± 2.62 6 1 .5 ± 2 .33 60.0 ± 2.05 
HepG2-Gal 47 . 1 ± 2.49 38 .7 ± 1 .55 33.6 ± 1 .40 29.9 ± 1 .58  
He�G2-Gal + Pio 46.6 ± 2.47 40.6 ± 1 . 80 37.2 ± 1 .50 34.4 ± 1 .29 
significantly higher than 30 min (Table 1 ) .  
Repeated two-way ANOV A showed significant interactions between time alone 
(T) , media composition alone (M) and the interaction between time, media and 
pioglitazone treatment on cellular energy transduction (Table 2) .  The heat generated per 
million cells measured every 30 minutes and monitored for 2 h had a strong positive 
correlation to each other (Table 3) .  
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Table 2:  Univariate Type III Repeated-Measures ANOVA Assuming Sphericity of 
change in cellular heat dissipation after galactose and pioglitazone treatment 
Source of variation DF F p 
Treatment (T) 1 ,32 0.78 0.38 
Media (M) 1 ,32 43 .68 <0.000 1 * * *  
T x M  1 ,32 0 .87 0 .35 
T x Time 3 , 96 3 .94 <0.05* 
M x Time 3 , 96 33 .59 <0.000 1 * * *  
T x  M x Time 3 , 96 3 .29 <0.05 * 
Table 3 :  Pairwise correlation analyses change in cellular heat dissipation after 
galactose and pioglitazone treatment 
30 Min 60 Min 90 Min 1 20 Min 
30 Min 1 0.89 0.85 0.82 
60 Min 1 0.99 0.97 
90 Min 1 0.99 
1 20 Min 1 
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DISCUSSION 
The results of the present study show that both treatment with D-galactose, (a 
simple reducing sugar) and mitoNEET overexpression significantly increased OXPHOS 
capacity in HepG2 cells . Furthermore, treatment of hepatocytes with pioglitazone 
significantly reduced OXPHOS (state 3) respiration. Interestingly, galactose treatment, 
pioglitazone treatment and mitoNEET overexpression each increased LEAKo respiration 
in HepG2 cells . 
Mitochondrial respiration is regulated by molecular redox state, the mitochondrial 
membrane potential (A\}'m) and proton motive force (PMF/Ap) ,  state of phosphorylation 
of ATP/ADP, ion gradient and cellular heat flow in response to intracellular and 
extracellular energy demands. Mitochondrial respiration in association with cytoplasmic 
glycolytic pathway provides comprehensive insight of cellular pathophysiology (Pesta 
and Gnaiger 20 1 2) .  
We found that D-galactose reduces endogenous mitoNEET levels in  HepG2 cells 
(Fig. 4). Reduction in mitoNEET levels increases iron content in the mitochondrial 
matrix resulting an enhanced mitochondrial respiration capacity (Kusminski et al. ,  20 1 2) .  
Immortalized cells grown in glucose continuously produce lactate, which inhibits 
mitochondrial respiration However, cells in galactose supplemented medium consume 
endogenous lactate (Altamirano et al. ,  2006) favoring mitochondrial respiration. A 
decreased mitoNEET level and the subsequent increase in mitochondrial iron content 
combined with endogenous lactate consumption might be the reason for increased 
respiration in HepG2 cells cultured in galactose medium (Fig. 10) .  
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Overexpression of mitoNEET reduces /1. 'I'm in adipocytes and decreases iron 
content in the mitochondrial matrix thereby increasing reactive oxygen species. 
Decreased /1. 'I'm is associated with insufficient electron transportation system (ETS) 
activity, inefficient substrate supply to the mitochondria or an increase in proton flux 
back into the mitochondrial matrix .  The observed high rate of respiration in mNT cells 
compared to HepG2 cells (Fig. l OB) might be due to iron induced ROS production 
(Kusminski et al. ,  20 1 2, Simcox and McClain 201 3) .  
In addition to ATP generation, free radicals are also generated as  a byproduct of 
OXPHOS in the inner mitochondrial membrane, which is the major source of reactive 
oxygen species (ROS) production and subsequent cellular damage. This process is highly 
dependent on /1. 'I'm. Electrons are leaked from complex I and complex III to the oxygen 
producing superoxide radicals . This facilitated proton diffusion is termed "proton leak". 
Complex I generates superoxide in the mitochondrial matrix which is believed to 
contribute much more than complex III to ROS production, whereas complex III 
generates ROS in both the inter membrane space and the matrix (Jastroch et al. ,  20 1 0) .  
Additionally, a-ketoglutarate dehydrogenase also contributes to superoxide generation in 
the mitochondrial matrix (Starkov et al. ,  2004) . Thermogenesis is also a major functions 
of LEAK respiration in adipocytes which is mediated by uncoupling proteins (UCPs) 
increasing proton leak and maintaining carbon flux despite low ATP demand in the cells. 
According to the uncoupling to survive hypothesis, proton leak has been considered as a 
pathway to minimize oxidative damage by moderating PMF and ROS production. 
Increased leak respiration in galactose and pioglitazone treated cells in this experiment 
(Fig. lOD) might be a mechanism to minimize oxidative damage adjusting 11.'l'm and 
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mitochondrial superoxide production (uncoupling to survive) (Divakaruni and Brand 
20 1 1 ,  Jastroch et al. ,  20 1 0) .  
Pioglitazone reduces the activity of the mitochondrial complex I by disassembling 
complex I subunits thereby depleting cellular ATP content. Genes encoding 
mitochondrial complex I subunits and complex III subunits are upregulated as a result of 
cellular ATP depletion in HepG2 cells and in mouse liver mitochondria (Garcia-Ruiz et 
al. ,  20 1 3) .  Pioglitazone inhibited state 3 respiration observed in this experiment (Fig. 
l OB) is perhaps due to disassembly of complex I subunits . 
Galactose treatment induces oxidative stress and mitochondrial damage thereby 
dissipating the electrochemical gradient across the inner mitochondrial membrane, 
causing a reduction in ATP synthesis (L6pez-Erauskin et al. ,  20 1 2) leading to a reduction 
in cell proliferation rates and lower carbon flow. This reduced carbon flow might be the 
cause behind low heat dissipation in HepG2 cells cultured in galactose medium (Table 1 ) .  
In conclusion, three significant findings from these experiments include 1 )  OXPHOS 
increases due to galactose treatment or mitoNEET overexpression in liver cancer cells, 2) 
Pioglitazone significantly reduces complex I respiration irrespective of mitoNEET levels 
and 3) and galactose reduces overall energy transduction in liver cancer cells . 
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CHAPTER THREE 
CO-IMMUNOPRECIPITATION ASSAY IDENTIFIES BINDING PARTNERS OF 
MITONEET 
ABSTRACT 
The recently discovered protein mitoNEET has been shown to play a central role 
in various metabolic processes including mitochondrial function, programmed cell death 
(apoptosis), and cell proliferation. However, a clear link between the mechanisms of 
mitoNEET' s functions and the physiological processes with which the protein is involved 
is still unresolved. A key question that remains is what protein(s) with known function 
acts as binding partner of mitoNEET. Knowing this would provide a better understanding 
into the mechanism by which mitoNEET integrates into physiological processes. To 
detect potential in vivo binding partners of mitoNEET, an in vitro assay termed co­
immunoprecipitation (Co-IP) was performed. A combined approach of the Co-IP assay, 
proteomics analysis and database search demonstrates that mitoNEET interacts with 
mitochondrial, cytoplasmic and nuclear proteins including the mitochondrial matrix heat 
shock proteins 60 (Hsp60) , 10  (Hsp l O) and aldolase enzymes. These results open new 
avenues for further research on elucidation of mitoNEET functions and its importance. 
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INTRODUCTION 
Mitochondrial functions and dysfunctions set the capacity of the organelle to 
supply ATP as per cellular ATP demand (Geldenhuys et al. ,  20 14) .  The exact cellular 
functions of the mitoNEET are still unclear but recent reports have been highlighting a 
role of mitoNEET in various metabolic and neurodegenerative diseases such as type II 
diabetes, Alzheimer' s disease and Parkinson ' s  disease. Furthermore, mitoNEET plays a 
vital role in mitochondrial bioenergetics, mitophagy, autophagy, apoptosis as well as 
cellular growth and development (Geldenhuys et al. ,  20 1 1 , Geldenhuys et al. ,  20 14).  It 
has been shown that mitoNEET interacts with other binding partners including ferredoxin 
and glutamate dehydrogenase 1 maintaining mitochondrial bioenergetics, mitochondrial 
ROS and iron homeostasis,  peripheral tissue insulin sensitivity, apoptosis regulation and 
mitophagy regulation (Colca et al. ,  2004, Paddock et al. ,  2007, Kusmins.ki et al., 201 2, , 
Roberts et al. ,  20 1 3  and Salem et al. ,  20 1 2) .  When mitoNEET is in the oxidized state 
such as when cells are stressed, mitoNEET transfers its iron-sulfur clusters [2Fe-2S] to an 
apo-acceptor protein (e.g.  ferredoxin), and functions as a redox sensor center (Zuris et al. ,  
20 1 1 ) .  Although, the effects of overexpression and knockdown of  mitoNEET in  insulin 
sensitivity and ROS homeostasis have been reported in a rodent model (Kusmins.ki et al. ,  
20 1 2) (also see Chapter 2), a clear link between the biochemical characteristics of 
mitoNEET, and the physiological consequences of mitoNEET levels on mitochondrial 
performance and oncogenesis is still unresolved. A key question that remains is, what 
protein(s) with known function(s) works as binding partner of mitoNEET to gain insight 
into the mechanisms of action of mitoNEET. Our laboratories recently demonstrated the 
interaction between glutamate dehydrogenase 1 (GDH l ) , described as a regulator of 
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insulin, and mitoNEET by forming a redox-sensitive disulfide bond (Roberts et al. ,  
201 3) .  Nevertheless, whether mitoNEET interacts with GDH l in vivo by the same 
mechanism is unknown. To answer this question, co-immunoprecipitation (CO-IP) assays 
were performed. 
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METHODS 
Co-immunoprecipitation assay 
Thermo Scientific Pierce™ Crosslink IP/Co-IP Kit (88805) was used to perform 
Co-IP assay following the manufacturer' s  protocol. Briefly, 2- l Oµg of anti-CISD l 
antibody (Mouse monoclonal [2B3] to CISD l )  was cross-linked and immobilized to 
protein beads provided. Lysis buffer was added to a monolayer of about 5x106 HepG2 
(ATCC HB-8065 , Manassas, VA) cells. After scraping the cells and centrifuging the 
lysate, the supernatant was applied to the antibody immobilized beads . Elutes were used 
for SDS-PAGE and Western blot analysis . A pre-cast SDS-PAGE gel (4- 1 5 %  TGX, Bio 
Rad, Hercules, CA) was run and the gel was subjected to silver staining using Thermo 
Scientific Pierce Silver Stain for Mass Spectrometry (#24600) kit following the 
manufacturer' s  protocol. Four protein bands were chosen based on their intensity and 
exhibited apparent molecular weights of approximately 1 2, 24, 60 and 70 kDa. The four 
bands were excised from the gel, de-stained using Thermo Scientific Pierce Silver Stain 
for Mass Spectrometry (24600) kit following the manufacturer' s  protocol and sent for 
proteomic analysis to be sequenced and identified. 
Proteomic Analysis 
All of the proteomic analyses were completed at Indiana University School of 
Medicine Proteomics Core Laboratory (Indianapolis,  IN) . The protein samples were 
digested by trypsin (Promega) overnight at 37°C after de-staining (with 10  mM DTT in 
10  mM ammonium bicarbonate) and alkylation (with 55 mM iodoacetamide prepared in 
10 mM ammonium bicarbonate) of gel bands. Digested peptides were extracted from the 
gel spots (with 1 )  50% ACN /49 .9%H20/0. l % TFA; 2) 99.9% ACN/0. 1 % TFA) and 
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injected onto NanoAcquity UPLC® column l OOµm x l OOmm, l .7µm BEH 1 30 C 1 8  
(Analytical column) and NanoAcquity UPLC® Trap column 1 80µm x 20mm, 5µm 
Symmetry C 1 8  (Trapping column) . A linear gradient of 3 to 40% acetonitrile (in water 
with 0. 1 % FA) was used to elute the peptides and effluent was electro-sprayed into the 
mass spectrometer (Thermo-Fisher Scientific Orbitrap Velos Pro and Waters Acquity 
UPLC system) . Blanks were run prior to the sample run to account for any background 
signals from solvents or the column. Database search was carried out using SequestTM 
algorithms against the latest Human DB from UniProt. 
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RESULTS 
Proteomics analysis and database searches performed after Co-IP assay using 
anti-CISD l  antibody for the pull-down experiment (Fig. 1 3 )  detected 8 different proteins. 
The majority of proteins identified are localized to the cytoplasm and mitochondrion. 
Uniprot database searches for the 
detected proteins revealed the protein 
Hsp60 (60 kDa chaperonin) which is 
localized to the mitochondrial matrix and 
delta (3 ,5 )-delta(2,4 )-dienoyl-CoA 
isomerase is localized to mitochondria, 
peroxisomes, extracellular exosomes and 
120 
85 
so 
3 5  
2 5  
2 0  
membranes . Heterogeneous nuclear Figure 1 3 .  SDS-PAGE gel after silver 
ribonucleoprotein A l  is localized to staining. Proteins isolated from two 
nucleus whereas the THO complex replicates of HepG2 cells (A and B) were 
subunit 4 is localized to nucleus, nucleus loaded on to the gel. Boxes shown by whit 
speckle and cytoplasm and both were arrows were incised and sent to proteomics 
identified as potential binding partners of analysis. Prestained protein serves as 
mitoNEET. THO complex, a nuclear protein ladder (L) . 
complex containing 5 subunits which is required for transcription elongation through 
genes comprising tandem repeat DNA sequences . 
Furthermore, glyceraldehyde-3-phosphate dehydrogenase (EC: 1 .2 . 1 . 1 2) ,  
fructose-bisphosphate aldolase B (EC :4. l .2 . 1 3) ,  and Hsp 10 were identified and all 
proteins localize to the cytoplasm (Table 1 ) .  
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Table 4: List of proteins detected using Co-IP, proteomics analysis and database search. 
SN Uniprot Proteins detected Gene 
names 
1 
2 
3 
4 
5 
6 
7 
8 
ID 
THOC4_ 
HUMAN 
THO complex 
(26.9kDa) 
subsunit 4 ALYREF 
(ALY, BEF, 
THOC4) 
ECHI_H Delta (3 ,5)-delta(2,4)-dienoyl-CoA ECHJ 
UMAN 
E7EUT5_ 
HUMAN 
ALDOB 
HUMAN 
H3BPS8_ 
HUMAN 
B8ZZL8_ 
HUMAN 
isomerase, mitochondrial (36 kDa) 
(EC:5 .3 .3 . )  
Glyceraldehyde-3-phosphate 
dehydrogenase (27 .8  kDa) 
(EC: l .2. 1 . 12) 
GAP DH 
Fructose-bisphosphate aldolase B ALDOB 
(39.5 kDa) (EC:4. l .2. 1 3) 
Liver-type aldolase 
Fructose-bisphosphate aldolase ALDOA 
(30.4 (kDa) (EC:4. l .2 . 1 3) 
10  kDa heat shock protein, HSPEJ 
mitochondrial/Heat shock 1 OkDa 
protein 1 (Chaperonin 1 0) ,  isoform 
CRA_b 
B7Z7 1 2_ 60 kDa heat shock protein (60 kDa HSPDJ 
HUMAN chaperonin) (6 1 kDa) 
HOYH80_ Heterogeneous nuclear HNRNPAJ 
HUMAN ribonucleoprotein Al  ( 1 9.4 kDa) 
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Subcellular 
localization 
Nucleus, nucleus 
speckle, cytoplasm 
Mitochondria and 
peroxysome 
Cytoplasm and 
membrane-bound 
organelle 
Cytoplasm and 
cytoskeleton 
Cytoplasm 
Cytoplasm/ 
mitochondria 
Mitochondrial 
matrix 
Nucleus 
DISCUSSION 
In this study we identified THO complex subunit 4, aldolases, HSP proteins and 
heterogeneous nuclear ribonucleoprotein Al  as potential binding partner of mitoNEET 
and the proteins are found in the nucleus, cytoplasm, mitochondria and peroxisomes. 
Molecular chaperones bind other nonnative proteins to assist them to fold and gain 
functional conformation after translation and guide these nonnative proteins to their 
target organelles .  They also participate in refolding of misfolded proteins, assembling and 
disassembling oligomeric protein structures and regulating biological activities of 
regulatory proteins including transcription factors . Furthermore, molecular chaperons 
involve in assisting degradation of unwanted proteins in expense of ATP (Bukau and 
Horwich 1 998) .  Although diverse classes of molecular chaperones have been reported, 
heat shock protein 70 (Hsp70) and Hsp60 (chaperonin) are the best characterized ones . 
But, Hsp60 are quickly sorted into the mitochondria (Itoh et al. ,  2002) . Similar to other 
Hsps, Hsp70 for example, a complex of mitochondrial Hsp60 and Hsp l O  participate in 
mitochondrial protein folding and their congregation (Nielsen et al. ,  1 999, Campanella et 
al. ,  2008).  Our results documents potential interaction of mitoNEET with mitochondrial 
matrix proteins including GDH l (Roberts et al. ,  20 1 3) which indicates possible presence 
of mitoNEET in mitochondrial matrix as well. 
The transcribed RNA molecules are transported to the cytoplasm through the 
nuclear pore complexes via export receptors . Unlike small RNAs (transported via simple 
export routs) ,  large RNAs (mRNA and rRNA) need complicated ribonucleoproteins 
(RNP) and adaptor proteins complex for transcription and export (TREX complex) 
(Kohler and Hurt 2007, Chavez et al 2000) . THO complex subunit 4 (THOC4) in 
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association with other proteins such as AL YREF, mediates the recruitment of TREX 
complex and nuclear transportation of spliced mRNA. For example, in combination with 
THOC5, THOC4 aids in the export of spliced HSP70 mRNA from the nucleus (StraBer et 
al. ,  2002) . Interaction of mitoNEET with Hsp60, Hsp l O, heterogeneous nuclear 
ribonucleoprotein (hnRNP) A l  and THO subunit 4 likely suggest its transcription, export 
and folding is mediated by the THO complex/ hnRNP Al  and aided by Hsp60/Hsp 10  
complexes . Furthermore, mutation in  HNRNPAJ gene which encodes hnRNP A l  causes 
symptoms similar to neurodegenerative diseases (Benatar et al. ,  20 1 3) and several recent 
studies have been reported a crucial role of mitoNEET in neurodegenerative diseases 
(Sain et al. ,  20 1 1 ,  Geldenhuys et al. ,  20 1 1 ) .  In addition to molecular chaperones, these 
Hsp help the cells survive to stressful conditions (Zligel and Kaufmann 1 999) . 
Hsp60/Hsp 1 0  complex functions as oxidative sensor center in mitochondria (Samali et 
al. ,  1 999) . Hsp l O  has also been reported to play a role in autoimmune inhibition in cancer 
(Jia et al. ,  20 1 1 ) .  
Several metabolic enzymes were identified in the pull-down assay such as 
fructose-bisphosphate aldolase (also termed aldolase) an enzyme that reversibly catalyzes 
degradation of carbohydrates in glycolysis. Similarly, glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) was identified which catalyzes the sixth step of glycolysis 
(glyceraldehyde-3phosphate to glyceraldehyde 1 ,3-biphosphate) .  Furthermore, GAPDH 
have been reported to play a role in apoptosis (Tarze et al. ,  2007) .  One of the causes of 
oxidative stress and glucose intolerance phenotypes observed with reduced mitoNEET 
levels in a rodent model (Kusminski et al. ,  20 1 2) could the interactions of mitoNEET 
with GAPDH and aldolases . Furthermore, mitoNEET lowers �-oxidation rate in a rodent 
7 1  
model (Kusminski et al. ,  20 1 2) that possibly could be due to an interaction with delta 
(3 ,5)-delta(2,4)-dienoyl-CoA isomerase enzyme which catalyzes isomerization of 3-
trans,5-cis-dienoyl-CoA to 2-trans,4-trans-dienoyl-CoA in lipid metabolism (fatty acid 
�-oxidation) pathway (Lou et al. ,  1 994) . In conclusion, the Co-IP assay identified 8 
potential binding partners of mitoNEET. These proteins have different localizations and 
functions. To confirm the biological relevance of any of these interactions further 
research is needed. 
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